Serina Therapeutics Inc（SER）價格預測SERSerina Therapeutics Inc

Alphio's SER stock price prediction model matches the current Serina Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.38 (+0.91%). The 1-week path is $1.38 (+1.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Serina Therapeutics Inc is a good buy right now due to its recent positive developments and potential for growth. The stock is currently priced at $1.85, significantly below its 52-week high of $4.99, indicating a potential upside. Additionally, the RSI is at 56.234, suggesting that the stock is not overbought, which is favorable for entry. The recent partnership with Gannet BioChem and FDA approval for SER-252 could drive future growth, with analysts projecting a price target of $8, which represents a potential upside of over 300%. However, the main risk is the negative earnings trend, with a reported EPS of -0.58 in the last quarter, indicating ongoing financial challenges.

Serina Therapeutics Inc (SER) last closed at $1.37, losing -16.97%. These facts feed the 1-day and 1-week SER price prediction above.